{
    "root": "342baa6d-1e7f-b803-e063-6294a90af841",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "Glipizide",
        "suffix": {
            "text": "ER"
        }
    },
    "value": "20250502",
    "ingredients": [
        {
            "name": "ACETYLTRIBUTYL CITRATE",
            "code": "0ZBX0N59RZ"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)",
            "code": "S38J6RZN16"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)",
            "code": "74G4R6TH13"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "GLIPIZIDE",
            "code": "X7WDT95N5C"
        }
    ],
    "indications": "Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
    "contraindications": "Recommended starting dose is 5 mg once daily. Dose adjustment can be made based on the patient’s glycemic control. Maximum recommended dose is 20 mg once daily ( 2.1 ). Administer with breakfast or the first meal of the day ( 2.1 ). For combination therapy with other blood-glucose-lowering agents, initiate the agent at the lowest recommended dose, and observe patients for hypoglycemia ( 2.2 ).",
    "warningsAndPrecautions": "Glipizide Extended-Release Tablets are supplied as 10 mg round, unscored, film-coated tablets and are printed with black ink as follows:\n                  10 mg tablets are white to off-white and printed with “\n \n  WPI” and “\n \n  845”. They are available in the following package sizes:\n\n \n                  NDC 55289-301-90 Bottles of 90\n                  NDC 55289-301-93 Bottles of 180\n                  Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture and humidity.",
    "adverseReactions": "Glipizide is contraindicated in patients with:\n                  \n                     Known hypersensitivity to glipizide or any of the product’s ingredients.\n                     Hypersensitivity to sulfonamide derivatives."
}